data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Hoth Therapeutics
(NASDAQ:HOTH)
$0.415
-0.0042[-1.00%]
At close: Jul 1
$0.405
-0.0100[-2.41%]
After Hours: 7:44PM EDT
Day High/Low0.4 - 0.43
52 Week High/Low0.38 - 1.75
Open / Close0.4 / 0.42
Float / Outstanding31.3M / 32.2M
Vol / Avg.259.3K / 4M
Mkt Cap13.4M
P/E-
50d Avg. Price0.46
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float31.3M

Hoth Therapeutics (NASDAQ:HOTH), Quotes and News Summary

Hoth Therapeutics (NASDAQ: HOTH)

Day High/Low0.4 - 0.43
52 Week High/Low0.38 - 1.75
Open / Close0.4 / 0.42
Float / Outstanding31.3M / 32.2M
Vol / Avg.259.3K / 4M
Mkt Cap13.4M
P/E-
50d Avg. Price0.46
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float31.3M
Benzinga - Sponsored
Benzinga - 2 days ago
Benzinga - Jun 21, 2022, 12:31PM
Benzinga - Jun 9, 2022, 8:22AM
Benzinga - May 3, 2022, 8:11AM
Benzinga - Apr 19, 2022, 3:29PM
Benzinga - Apr 19, 2022, 11:37AM
Benzinga - Apr 19, 2022, 10:30AM
Benzinga - Apr 12, 2022, 8:22AM
Benzinga - Apr 11, 2022, 5:06PM
Benzinga - Apr 11, 2022, 4:21PM
Benzinga - Apr 11, 2022, 10:17AM
Benzinga - Apr 11, 2022, 10:14AM
Benzinga - Apr 11, 2022, 8:37AM
Benzinga - Apr 11, 2022, 8:10AM
Benzinga - Apr 11, 2022, 8:09AM
Benzinga - Apr 5, 2022, 8:03AM
Benzinga - Apr 1, 2022, 8:06AM
Benzinga - Mar 31, 2022, 9:43AM
Benzinga - Mar 22, 2022, 9:49AM
Benzinga - Mar 11, 2022, 8:01AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-10
REV
Q1 2022Est.ActualSurprise
EPS-0.110
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Hoth Therapeutics Questions & Answers

Q
How do I buy Hoth Therapeutics (HOTH) stock?
A

You can purchase shares of Hoth Therapeutics (NASDAQ: HOTH) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Hoth Therapeutics's (HOTH) competitors?
Q
What is the target price for Hoth Therapeutics (HOTH) stock?
A

The latest price target for Hoth Therapeutics (NASDAQ: HOTH) was reported by EF Hutton on Thursday, March 31, 2022. The analyst firm set a price target for 2.50 expecting HOTH to rise to within 12 months (a possible 502.41% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Hoth Therapeutics (HOTH)?
A

The stock price for Hoth Therapeutics (NASDAQ: HOTH) is $0.415 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Hoth Therapeutics (HOTH) pay a dividend?
A

There are no upcoming dividends for Hoth Therapeutics.

Q
When is Hoth Therapeutics (NASDAQ:HOTH) reporting earnings?
A

Hoth Therapeutics’s Q2 earnings are confirmed for Wednesday, August 10, 2022.

Q
Is Hoth Therapeutics (HOTH) going to split?
A

There is no upcoming split for Hoth Therapeutics.

Q
What sector and industry does Hoth Therapeutics (HOTH) operate in?
A

Hoth Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.